{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:32:58Z","timestamp":1791498778648,"version":"4.3.4"},"reference-count":80,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:p>The landscape of research on the benefits of influenza vaccines and antivirals to protect pregnant persons and infants has increased in recent years, while influenza vaccination rates and antiviral usage have declined. Pregnant people and infants &lt;6 months of age are at increased risk of hospitalization with influenza, making protection of this population essential. Maternal influenza vaccination at any time during pregnancy is the best way to reduce the risk of influenza and severe influenza in both pregnant people and their infants &lt;6 months of age. Influenza antiviral medications for pregnant people and infants are also recommended as early as possible if influenza is confirmed or suspected. This report will update on the current research on the benefits of influenza vaccination during pregnancy and influenza antiviral medication for the pregnant person and infant, current Advisory Committee on Immunization Practices recommendations for influenza vaccination in pregnancy and vaccination coverage rates, current influenza antiviral medication guidance and usage rates in pregnancy and among infants, and future directions for influenza pregnancy research. With over half a century of maternal influenza vaccination in the United States, we have improved protection for pregnant persons and infants against influenza, but we still have room for improvement and optimization with new challenges to overcome following the COVID-19 pandemic. By continuing to fill research gaps and increase vaccination coverage and antiviral usage, there is potential for significant reductions in the domestic and global burden of influenza in pregnant persons and infants.<\/jats:p>","DOI":"10.1089\/jwh.2024.0893","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T23:41:18Z","timestamp":1730677278000},"page":"1591-1598","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0589-5766","authenticated-orcid":false,"given":"Samantha M.","family":"Olson","sequence":"first","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah S.","family":"Dawood","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Grohskopf","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ellington","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.012"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000005750"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.04.009"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6840e1"},{"key":"e_1_3_4_6_2","unstructured":"CDC. Pregnant people hit hard by flu but many remain unvaccinated. 2022. Available at. https:\/\/www.cdc.gov\/flu\/spotlights\/2022-2023\/pregnant-people-flu-vaccine.htm"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7305a1"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.061435"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009587"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/M21-3668"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d99d85"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5061"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12977"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30592-2"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw033"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det455"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac296"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piy101"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708630"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401480"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(17)30252-9"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(16)30054-8"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy737"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit750"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12947"},{"key":"e_1_3_4_26_2","unstructured":"CDC. Past seasons\u2019 vaccine effectiveness estimates. 2024. Available at https:\/\/www.cdc.gov\/flu\/vaccines-work\/past-seasons-estimates.html"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.03.042"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/657309"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.192"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.02.042"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2023.5639"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad539"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.02.044"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318242af27"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.2307\/4590965"},{"key":"e_1_3_4_36_2","unstructured":"Arden NH Cox N Schonberger LB. Prevention and control of influenza: Advisory Committee on Immunization Practices. 1995."},{"issue":"1","key":"e_1_3_4_37_2","first-page":"1","article-title":"Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","author":"Fiore AE","year":"2011","unstructured":"Fiore AE, , Fry A, , Shay D, et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep, 2011; 60(1):1\u201324.","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"e_1_3_4_38_2","first-page":"1","article-title":"Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Harper SA","year":"2005","unstructured":"Harper SA, , Fukuda K, , Uyeki TM, et al. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2005; 54(RR-8):1\u201340.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_4_39_2","unstructured":"Arden NH Cox N Schonberger LB. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1997."},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1460297"},{"key":"e_1_3_4_41_2","unstructured":"CDC. Recombinant influenza (flu) vaccine. 2023. Available at https:\/\/www.cdc.gov\/flu\/prevent\/qa_flublok-vaccine.htm"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7005a1"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7101a1"},{"key":"e_1_3_4_44_2","unstructured":"Centers for Disease Control and Prevention. US will transition to trivalent flu vaccines for 2024-2025. 2024. Available at https:\/\/www.cdc.gov\/flu\/spotlights\/2023-2024\/trivalent-vaccines-2024-2025.htm"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.045"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101600"},{"key":"e_1_3_4_47_2","unstructured":"Swamy G. Clinical trial to compare safety of recombinant influenza vaccine (RIV4) versus quadrivalent inactivated influenza vaccine (IIV4) in pregnancy (ClinicalTrials.gov NCT03969641). 2022. Available at https:\/\/stacks.cdc.gov\/view\/cdc\/122379"},{"key":"e_1_3_4_48_2","unstructured":"Klein N. Safety of quadrivalent recombinant influenza vaccine in pregnant women and their infants. 2023. Available at https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-10-25-26\/02-influenza-klein-508.pdf"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000005285"},{"key":"e_1_3_4_50_2","unstructured":"Centers for Disease Control and Prevention. Influenza vaccination coverage pregnant persons United States. 2024. Available at https:\/\/www.cdc.gov\/flu\/fluvaxview\/dashboard\/vaccination-coverage-pregnant.html"},{"key":"e_1_3_4_51_2","unstructured":"Centers for Disease Control and Prevention. Healthy People 2020 Progress Table. 2023. Available at https:\/\/www.cdc.gov\/nchs\/healthy_people\/hp2020\/progress-tables.htm"},{"issue":"32","key":"e_1_3_4_52_2","first-page":"1078","article-title":"Influenza vaccination coverage among pregnant women\u2014United States, 2010-11 influenza season","volume":"60","author":"CDC","year":"2011","unstructured":"CDC. Influenza vaccination coverage among pregnant women\u2014United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep, 2011; 60(32):1078\u20131082.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7239a4"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000005101"},{"key":"e_1_3_4_55_2","unstructured":"CDC. New wild to mild campaign drives key message to tame flu and reset expectations. 2023. Available at https:\/\/www.cdc.gov\/flu\/spotlights\/2023-2024\/new-campaign-wild-to-mild.htm"},{"key":"e_1_3_4_56_2","unstructured":"CDC. From me to you. 2024. Available at https:\/\/www.cdc.gov\/vaccines\/events\/from-me-to-you.html"},{"key":"e_1_3_4_57_2","unstructured":"Centers for Disease Control and Prevention. Influenza antiviral medications: Summary for clinicians. 2023. Available at https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910444"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy866"},{"key":"e_1_3_4_60_2","unstructured":"ACOG Committee Statement. Influenza in pregnancy: Prevention and treatment. 2024."},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.07.007"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063773"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis765"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33027"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7241a2"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2022.0030"},{"key":"e_1_3_4_67_2","unstructured":"CDC. Flu Tdap and COVID-19 vaccination coverage among pregnant women\u2014United States April 2022. 2023. Available at https:\/\/www.cdc.gov\/flu\/fluvaxview\/pregnant-women-apr2022.htm"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.7776"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2156229"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2264"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.22353"},{"key":"e_1_3_4_72_2","unstructured":"Clinicaltrials.gov. A study to evaluate the safety tolerability and immunogenicity of combined modified RNA vaccine candidates against COVID-19 and influenza. 2024. Available at https:\/\/clinicaltrials.gov\/study\/NCT05596734?cond=covid%20influenza&term=pfizer%20biontech&rank=2"},{"key":"e_1_3_4_73_2","unstructured":"Clinicaltrials.gov. A study of mRNA-1083 (SARS-CoV-2 and influenza) vaccine in healthy adult participants \u226550 years of age. 2024. Available at https:\/\/clinicaltrials.gov\/study\/NCT06097273"},{"key":"e_1_3_4_74_2","unstructured":"Clinicaltrials.gov. A study to evaluate the safety and immunogenicity of a single dose of H1ssF-3928 mRNA-LNP in healthy adults. 2024. Available at https:\/\/clinicaltrials.gov\/study\/NCT05755620"},{"key":"e_1_3_4_75_2","unstructured":"Clinicaltrials.gov. A study to evaluate a modified RNA vaccine against influenza in adults 18 years of age or older. 2024. Available at https:\/\/www.clinicaltrials.gov\/study\/NCT05540522"},{"key":"e_1_3_4_76_2","unstructured":"Clinicaltrials.gov. Study of mRNA-1010 Seasonal Influenza Vaccine in Adults (IGNITE P303). 2024. Available at https:\/\/clinicaltrials.gov\/study\/NCT05827978"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48555-z"},{"key":"e_1_3_4_78_2","unstructured":"UK Health Security Agenda. Flu vaccination programme 2023 to 2024: Information for healthcare practitioners. 2023. Available at https:\/\/www.gov.uk\/government\/publications\/flu-vaccination-programme-information-for-healthcare-practitioners\/flu-vaccination-programme-2023-to-2024-information-for-healthcare-practitioners"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101427"},{"key":"e_1_3_4_80_2","unstructured":"Government of Canada. Influenza vaccines: Canadian Immunization Guide. 2023. Available at https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-10-influenza-vaccine.html#a6.3"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1405188"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2024.0893","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2024.0893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2024.0893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:02:38Z","timestamp":1777658558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2024.0893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1089\/jwh.2024.0893"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2024.0893","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}